SkyView Investment Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
DAM
F
SkyView Investment Advisors's NVO Position: Q1 2026 in Review
SkyView Investment Advisors increased its Novo Nordisk (NVO) stake by 1.9% in Q1 2026, buying an estimated $16.6K and bringing the position to 19,010 shares worth $699K. The position accounts for 0.09% of the portfolio, ranked #161.
SkyView Investment Advisors first reported a position in NVO in Q4 2020 and has held it in 19 quarters since. The position peaked at $2.02M in Q2 2024. 1,277 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- SkyView Investment Advisors held 19,010 shares of Novo Nordisk worth $699K as of Q1 2026.
- SkyView Investment Advisors bought 351 Novo Nordisk shares in Q1 2026, an estimated $16.6K.
- Novo Nordisk made up 0.09% of SkyView Investment Advisors's portfolio in Q1 2026, its #161 holding.
- SkyView Investment Advisors first reported a position in Novo Nordisk in Q4 2020 and has held it in 19 quarters since.
- SkyView Investment Advisors's Novo Nordisk position peaked at $2.02M in Q2 2024.
- 1,277 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on SkyView Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.